NEOADJUVANT THERMOCHEMORADIOTHERAPY USING INTRARECTAL 5-FLUORURACIL IN COMBINED TREATMENT OF RECTAL CANCER
https://doi.org/10.17650/2220-3478-2013-0-1-11-18
Abstract
Safety and efficacy of intrarectal 5-fluoruracil in combined treatment of localized rectal cancer was investigated in this article. Our data supports safety, economical efficacy and simplicity of use of this method. It improves sphincter preservation rate in patients with distal rectal cancer, does not increase surgical mortality and morbidity, leads to high tumor regression rate, improves local control and decreases distant failure rate.
About the Authors
Yu. A. Barsukov
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
S. I. Tkachev
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
N. D. Oltarzhevskaya
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
D. V. Kuzmichev
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
Z. Z. Mamedli
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
A. M. Pavlova
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
A. G. Malikhov
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
E. N. Kholyavka
N.N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences, Moscow
Russian Federation
Russian Federation
References
1. Glimelius B. Chemoradiotherapy for rectal cancer – is there an optimal combination? Ann Oncol 2001 Aug;12(8):1039–45.
2. Grann A., Minsky B.D., Cohen A.M. Preliminary results of preoperative 5-fluorouracil, low dose leucovorin, and concurrent radiation therapy for resectable T3 rectal cancer. Dis Colon Rectum 1997;40(5):515–22.
3. Ichikawa D., Yamaguchi T., Yoshioka Y. et al. Prognostic evaluation of preoperative combined treatment for advanced cancer in the lower rectum with radiation, intraluminal hyperthermia, and 5-fluorouracil suppository. Am J Surg 1996 Mar;171(3):346–50.
4. Ngan S.Y., Michael M., Mackay J. et al. A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer. Br J Cancer 2004;91(6):1019–24.
5. O’Neil B.H., Tepper J.E. Current options for the management of rectal cancer. Curr Treat Options Oncol 2007;8(5):331–8.
6. Барсуков Ю.А. и др. Комбинированное и комплексное лечение больных раком прямой кишки. М., 2011. 96 с.
7. NCCN: Clinical Practice Guidelines in Oncology. Rectal Cancer, v.2. 4.2013.
8. Glimelius B., Oliveira J., and ESMO Guidelines Working Group. Rectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2009;20 Suppl 4:54–6.
9. Schüller J., Cassidy J., Dumont E. et al. Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patients. Cancer Chemother Pharmacol 2000;45(4):291–7.
10. Hoff P.M., Ansari R., Batist G. et al. Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first line treatment in 605 patients with metastatic сolorectal cancer: results of a randomized phase III study. J Clin Oncol 2001;19:2282–92.
11. De Paoli A., Chiara S., Luppi G. et al. Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study. Ann Oncol 2006;17(2):246–51.
12. Dunst J., Reese T., Sutter T. et al. Phase I trial evaluating the concurrent combination of radiotherapy and capecitabine in rectal cancer. J Clin Oncol 200;20(19):3983–91.
13. Пелевина И.И., Воронина С.С., Каракуло в Р.К. и др. Метронидазол, основные экспериментальные результаты, перспективы для клиники. Мед радиол 1984;2:10–20.
14. Холин В.В. Радиобиологические основы лучевой терапии злокачественных опухолей. Л.:Медицина, 1979. 223 с.
15. Takahashi T., Horie H., Kojima O., Itoh M. Preoperative combined treatment with radiation, intraluminal hyperthermia, and 5-fluorouracil suppositories for patients with rectal cancer. Surg Today 1993;23(12):1043–8.
16. National Cancer Institute, Common Terminology Criteria for Adverse Events (CTCAE) v3.0.
17. Лавникова Г.А. Некоторые закономерности лучевого патоморфоза опухолей человека и их практическое использование. Вестник АМН СССР 1976;6:13–9.
18. Dworak O., Keilholz L., Hoffmann A. Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 1997;12:19–23.
Review
Views:
613
Email this article 